Stocksigma LogoStocksigma Logo

Jeevan Scientific Reports Zero Deviation in Preferential Issue Fund Utilization

Jeevan Scientific Technology Limited reported no deviation in utilizing proceeds from its preferential equity allotment for the quarter ended 30th Sep'26

Jeevan Scientific Reports Zero Deviation in Preferential Issue Fund Utilization

Jeevan Scientific Technology Ltd · Others (Uncategorized) · 11 Nov 2026, 11:45 pm

Jeevan Scientific Reports Zero Deviation in Preferential Issue Fund Utilization Jeevan Scientific Technology Limited reported no deviation in utilizing proceeds from its preferential equity allotment for the quarter ended 30th Sep'26. Out of ₹3,074 lakhs raised on 2nd Jan'26, the company has deployed ₹414.46 lakhs toward capex (₹500 lakhs allocated), ₹279.97 lakhs for working capital (₹350 lakhs allocated), ₹300.53 lakhs for subsidiary requirements (₹500 lakhs allocated), ₹300.00 lakhs toward API/formulation unit acquisitions (₹1,000 lakhs allocated), and ₹189.04 lakhs for general corporate purposes (₹724 lakhs allocated).

Original exchange filing (PDF)

More announcements from Jeevan Scientific Technology Ltd

All Jeevan Scientific Technology Ltd announcements